Drug intelligence / Profile preview

fuzheng huayu

Development stage
Phase 4
Lead developer
Baheal Pharma
Administration
Oral
01

Overview

**Fuzheng Huayu** is an orally administered, multi-herb traditional Chinese medicine formula developed for hepatic fibrosis associated with chronic liver disease. The proprietary formulation contains *Salvia miltiorrhiza*, fermented *Cordyceps* mycelium powder, peach kernel, pine pollen, *Gynostemma pentaphyllum*, and processed *Schisandra chinensis*. It is marketed in China for hepatitis B-associated liver fibrosis and has been evaluated clinically for hepatic fibrosis in chronic hepatitis C and in metabolic dysfunction-associated fatty liver cirrhosis. Its proposed antifibrotic activity is multi-component and multi-pathway rather than attributable to a single defined molecular target; nonclinical studies associate the formula with reduced hepatic stellate-cell activation, attenuation of inflammatory and oxidative injury, and remodeling of fibrotic extracellular matrix.

Brand names
Ganxianle
Other names
FZHYFuzheng Huayu formulaFuzheng Huayu capsuleFuzheng Huayu tablet扶正化瘀扶正化瘀胶囊扶正化瘀片
02

Targets

SMAD2 (Mothers against decapentaplegic homolog 2)TGFBR1TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on fuzheng huayu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuzheng huayu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call